- Home
- RPRX vs KEY Comparison
RPRX vs KEY Comparison
Compare RPRX & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- KEY
- Stock Information
- Founded
- RPRX 1996
- KEY 1825
- Country
- RPRX United States
- KEY United States
- Employees
- RPRX N/A
- KEY N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- KEY Major Banks
- Sector
- RPRX Health Care
- KEY Finance
- Exchange
- RPRX Nasdaq
- KEY Nasdaq
- Market Cap
- RPRX 14.2B
- KEY 16.5B
- IPO Year
- RPRX 2020
- KEY N/A
- Fundamental
- Price
- RPRX $34.02
- KEY $16.63
- Analyst Decision
- RPRX Strong Buy
- KEY Buy
- Analyst Count
- RPRX 4
- KEY 19
- Target Price
- RPRX $42.50
- KEY $18.95
- AVG Volume (30 Days)
- RPRX 3.9M
- KEY 11.5M
- Earning Date
- RPRX 05-08-2025
- KEY 04-17-2025
- Dividend Yield
- RPRX 2.59%
- KEY 4.93%
- EPS Growth
- RPRX 37.60
- KEY N/A
- EPS
- RPRX 2.45
- KEY N/A
- Revenue
- RPRX $2,263,845,000.00
- KEY $4,464,000,000.00
- Revenue This Year
- RPRX $31.16
- KEY $74.95
- Revenue Next Year
- RPRX $5.86
- KEY $6.35
- P/E Ratio
- RPRX $13.85
- KEY N/A
- Revenue Growth
- RPRX 1.13
- KEY N/A
- 52 Week Low
- RPRX $24.05
- KEY $12.73
- 52 Week High
- RPRX $34.20
- KEY $20.04
- Technical
- Relative Strength Index (RSI)
- RPRX 61.77
- KEY 66.27
- Support Level
- RPRX $32.18
- KEY $15.39
- Resistance Level
- RPRX $34.11
- KEY $15.68
- Average True Range (ATR)
- RPRX 0.82
- KEY 0.33
- MACD
- RPRX 0.09
- KEY 0.20
- Stochastic Oscillator
- RPRX 91.93
- KEY 96.26
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About KEY KeyCorp
With assets of over $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.